Wiken TH, Høivik ML, Anisdahl K, Buer L, Warren DJ, Bolstad N, Hagen M, Moum BA, Medhus AW(2024) Subcutaneous Vedolizumab Treatment in a Real-World Inflammatory Bowel Disease Cohort Switched From Intravenous Vedolizumab: Eighteen-Month Prospective Follow-up Study Crohns Colitis 360, 6(1), otae013 DOI 10.1093/crocol/otae013, PubMed 38544907
Druckrey-Fiskaaen KT, Vold JH, Madebo T, Midgard H, Dalgard O, Leiva RA, Fadnes LT, INTRO-HCV Study Group(2024) Liver stiffness and associated risk factors among people with a history of injecting drugs: a prospective cohort study Subst Abuse Treat Prev Policy, 19(1), 21 DOI 10.1186/s13011-024-00603-z, PubMed 38532435
Anisdahl K, Lirhus SS, Medhus AW, Moum B, Melberg HO, Høivik ML(2024) Frailty risk and treatment strategy in elderly-onset inflammatory bowel disease. A Norwegian nationwide population-based registry study Dig Liver Dis(in press) DOI 10.1016/j.dld.2024.02.002, PubMed 38433021